INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹376 Cr | ₹294 Cr | ₹278 Cr | ₹315 Cr | ₹215 Cr |
What is the latest Total Current Liabilities ratio of INNOVA CAPTAB ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹376 Cr |
| Mar2024 | ₹294 Cr |
| Mar2023 | ₹278 Cr |
| Mar2022 | ₹315 Cr |
| Mar2021 | ₹215 Cr |
How is Total Current Liabilities of INNOVA CAPTAB Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹376 Cr | 28.05 | |
| Mar2024 | ₹294 Cr | 5.92 | |
| Mar2023 | ₹278 Cr | -12.02 | |
| Mar2022 | ₹315 Cr | 46.63 | |
| Mar2021 | ₹215 Cr | - | |
Compare Total Current Liabilities of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,948.2 Cr | -1.8% | -5.5% | -32.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -1.8% |
-5.5% |
-32.5% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses